O’Melveny’s Representation of Progenics Pharmaceuticals in its Acquisition of Molecular Insight Reported in Daily Journal

January 25, 2013

The January 25, 2013, Daily Journal article “O'Melveny aids pharmaceutical company in all-stock acquisition of cancer drug maker,” reported on O’Melveny’s representation of Progenics Pharmaceuticals Inc. in an all-stock exchange acquisition of Molecular Insight Pharmaceuticals Inc. The Firm’s team was led by partner Jennifer DePalma, counsel Stanton J. Lovenworth, and associate Ruchun Ji.